1.22
—
Close of 26 Oct 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Cryosite
Its shares trade on ASX under the ticker CTE.AX. It has been listed since 9 May 2002. In the fiscal year to 30 June 2026, it reported revenue of A$16.7m and net income of A$2.2m. At that date it held total assets of A$26.0m and shareholders' equity of A$4.8m.
Cryosite Ltd. engages in the provision of long term storage, supply chain logistics management of pharmaceutical products used in clinical trials and biological materials. The company is headquartered in Sydney, New South Wales. The company went IPO on 2002-05-09. The firm is engaged in cryopreservation and expansion of mesenchymal stem cells (MSCs) from umbilical cord tissue. The firm operates through two segments: Individualised Consumer Biologics, and Scientific Processing and Logistics. The Individualised Consumer Biologics segment provides cord tissue MSC banking to parents, and specialized contract good manufacturing practice (GMP) manufacturing and associated consultancy services to therapeutic and regenerative medicine companies involved in the development and commercialization of technologies. The Scientific Processing and Logistics segment provides specialized commercial drug distribution. The firm also provides specialized bio-repository, clinical trials logistics, commercial drug distribution, contract cellular therapies manufacturing and associated consultancy services to commercial clients both within Australia and internationally.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 9 May 2002
- Employees
- 34
- Website
- cryosite.com ↗
Leadership
Pay as last reported
- Mr. Mark KerrNon-Executive Chairman of the Board
- Mr. John HoggChief Executive Officer, since 2020
- Mr. Andrew KerrExecutive Director, since 2024
- Mr. Michael AustinJoint Company Secretary
- Mr. Hamish GeorgeJoint Company Secretary
- Mr. Scott ThomasDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Cryosite Ltd has a strong reputation as a leader in the field of cryogenic storage and services.
- The company possesses state-of-the-art facilities and technological expertise, ensuring high-quality and reliable cryopreservation solutions.
- Cryosite Ltd has a diversified customer base, including pharmaceutical companies, research institutions, and healthcare organizations.
Weaknesses
- The company heavily relies on the stability of its customer relationships, making it susceptible to potential loss of clients.
- Cryosite Ltd's services are highly specialized and may be more expensive compared to competitors, potentially limiting market share.
- There may be regulatory challenges related to the cryopreservation industry that could affect the company's operations.
Opportunities
- Increasing demand for cryogenic storage is expected in various sectors, such as biotechnology and regenerative medicine, providing growth opportunities for Cryosite Ltd.
- The company can expand its services to new geographic regions or target niche markets to capture additional market share.
- Technological advancements in cryopreservation techniques may open doors for innovative product offerings by Cryosite Ltd.
Threats
- Intense competition within the cryogenic storage industry poses a threat to Cryosite Ltd's market position and profitability.
- Economic fluctuations and uncertain financial conditions can negatively impact customer spending, affecting demand for cryopreservation services.
- Changes in regulations or legal frameworks governing cryogenic storage could impose compliance challenges and increase operating costs for the company.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.